Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China
· Delayed Price · Currency is CNY 20.59
+0.10 (0.49%)
May 13, 2025, 2:45 PM CST
SHA:600079 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,330 | 2,134 | 2,484 | 1,317 | 1,006 | Upgrade
|
| Depreciation & Amortization | 885.74 | 811.99 | 748.05 | 679.34 | 680.67 | Upgrade
|
| Other Amortization | 157.25 | 13.42 | 15.18 | 15.63 | 28.79 | Upgrade
|
| Loss (Gain) From Sale of Assets | 4.47 | 1.08 | 38.76 | -26.06 | 3.35 | Upgrade
|
| Asset Writedown & Restructuring Costs | 323 | 53.93 | 84.48 | 49.85 | 54.65 | Upgrade
|
| Loss (Gain) From Sale of Investments | -197.35 | -356.95 | -882.3 | -324.12 | -344.48 | Upgrade
|
| Provision & Write-off of Bad Debts | 124.76 | 72.55 | 57.52 | 48.15 | 19.33 | Upgrade
|
| Other Operating Activities | 967.21 | 1,094 | 764.77 | 1,146 | 1,720 | Upgrade
|
| Change in Accounts Receivable | -764.55 | -1,070 | -916.36 | -789.27 | -635.87 | Upgrade
|
| Change in Inventory | -0.46 | -200.36 | -360.79 | -486.24 | -93.71 | Upgrade
|
| Change in Accounts Payable | -679.48 | -643.33 | 151.96 | 515.47 | -365.15 | Upgrade
|
| Change in Other Net Operating Assets | 13.27 | 43.18 | 105.83 | 43.94 | - | Upgrade
|
| Operating Cash Flow | 2,164 | 1,967 | 2,441 | 2,179 | 2,090 | Upgrade
|
| Operating Cash Flow Growth | 10.02% | -19.41% | 12.04% | 4.26% | 2.55% | Upgrade
|
| Capital Expenditures | -1,021 | -1,958 | -3,113 | -1,703 | -1,098 | Upgrade
|
| Sale of Property, Plant & Equipment | 36.18 | 45.03 | 97.64 | 84.29 | 344.13 | Upgrade
|
| Cash Acquisitions | -53.04 | - | - | -36.66 | -7.85 | Upgrade
|
| Divestitures | 220.62 | 20.97 | 286.52 | 34.97 | 1,466 | Upgrade
|
| Investment in Securities | 49.36 | 559.8 | 3,451 | 202.53 | -494.37 | Upgrade
|
| Other Investing Activities | 25.8 | 107.81 | 505.45 | -2.3 | 91.38 | Upgrade
|
| Investing Cash Flow | -742.03 | -1,225 | 1,227 | -1,420 | 301.68 | Upgrade
|
| Short-Term Debt Issued | 494.78 | 1,172 | 1,577 | 721.22 | 2,461 | Upgrade
|
| Long-Term Debt Issued | 9,348 | 9,469 | 9,476 | 10,758 | 13,503 | Upgrade
|
| Total Debt Issued | 9,843 | 10,641 | 11,052 | 11,479 | 15,964 | Upgrade
|
| Short-Term Debt Repaid | -449.72 | -1,721 | -2,097 | -1,370 | -3,779 | Upgrade
|
| Long-Term Debt Repaid | -9,461 | -10,173 | -12,104 | -11,490 | -10,573 | Upgrade
|
| Total Debt Repaid | -9,910 | -11,894 | -14,201 | -12,860 | -14,353 | Upgrade
|
| Net Debt Issued (Repaid) | -67.5 | -1,253 | -3,148 | -1,381 | 1,611 | Upgrade
|
| Issuance of Common Stock | - | - | 9.97 | 1,270 | - | Upgrade
|
| Repurchase of Common Stock | -1.64 | -3.89 | -4.63 | - | -450.12 | Upgrade
|
| Common Dividends Paid | -1,269 | -587.69 | -612.92 | -665.55 | -709.93 | Upgrade
|
| Other Financing Activities | -159.54 | -260.67 | -488.88 | -138.11 | -251 | Upgrade
|
| Financing Cash Flow | -1,498 | -2,106 | -4,245 | -914 | 200.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | -23.87 | 16.3 | 48.45 | -24.96 | -105.99 | Upgrade
|
| Net Cash Flow | -99.62 | -1,347 | -528.63 | -180.35 | 2,486 | Upgrade
|
| Free Cash Flow | 1,143 | 8.93 | -672.27 | 475.78 | 991.85 | Upgrade
|
| Free Cash Flow Growth | 12703.33% | - | - | -52.03% | -19.25% | Upgrade
|
| Free Cash Flow Margin | 4.50% | 0.04% | -3.01% | 2.31% | 4.80% | Upgrade
|
| Free Cash Flow Per Share | 0.70 | 0.01 | -0.42 | 0.30 | 0.72 | Upgrade
|
| Cash Income Tax Paid | 1,872 | 1,761 | 1,691 | 1,203 | 1,151 | Upgrade
|
| Levered Free Cash Flow | 1,088 | -1,760 | -1,365 | 244.27 | 1,631 | Upgrade
|
| Unlevered Free Cash Flow | 1,308 | -1,539 | -1,067 | 620.61 | 2,152 | Upgrade
|
| Change in Net Working Capital | 597.67 | 2,480 | 372.49 | -153.02 | -880.27 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.